Acquisition History TheraDoc has a history of being acquired and integrated into larger healthcare service platforms (bought by Hospira in 2009 and later sold to Premier in 2014), suggesting potential alignment with enterprise buyers and influence within Premier's ecosystem for cross-sell of surveillance and decision support solutions.

Growth Potential With a revenue range of 10M to 25M and a lean employee base (11-50), TheraDoc represents a mid-market healthcare tech asset with room for scale through expanded clinical surveillance offerings, analytics, and AI-enabled decision support marketed to hospitals and health systems.

Partnership Footprint Recent partnerships involving Premier and GRAIL indicate openness to collaborations that leverage clinical performance improvement platforms, which creates opportunities to position TheraDoc's surveillance tools as a complementary solution within broader care delivery improvements.

Technology Stack The company utilizes a modern tech stack including AWS, Tealium, Marketo, and Cloudinary, signaling a capability to integrate with cloud-based workflows and marketing automation—opening doors for selling integration, data modernization, and patient safety analytics to tech-forward health systems.

Market Positioning As a former leader in clinical surveillance software with a niche in infection control and patient safety, TheraDoc can be positioned to compete for enterprise contracts against larger vendors by emphasizing specialization, reliability, and a proven track record within Premier's network.